Presence of foam cells in kidney interstitium is associated with progression of renal injury in patients with glomerular diseases

Nephron - Clinical Practice

Volumn 113, Issue 3, 2009, Pages

  Wu, Yan ^a   Chen, Yan ^a   Chen, Dan ^a   Zeng, Caihong ^a   Li, Leishi ^a   Liu, Zhihong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Alport syndrome; Foam cells; Glomerulonephritis; Hyperlipidemia; Proteinuria

Indexed keywords

LIPID;

ADULT; ALPORT SYNDROME; ARTICLE; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FOAM CELL; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IDIOPATHIC MEMBRANOUS NEPHROPATHY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY INJURY; KIDNEY INTERSTITIUM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; DISEASE PROGRESSION; EXTRACELLULAR FLUID; FEMALE; FOAM CELLS; GLOMERULONEPHRITIS; HUMANS; HYPERLIPIDEMIAS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 68349092693     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232596     Document Type: Article

References (24)

1. Risdon RA, Sloper JC, De Wardenner HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968; 2: 363-366.
2. Nath KA: The tubulointerstitium in progressive renal disease. Kidney Int 1998; 54: 992-994.
3. Mackensen-Haen S, Bader R, Grund KE, Bohle A: Correlation between renal cortical interstitial fibrosis, atrophy of proximal tubules and impairment of glomerular filtration rate. Clin Nephrol 1981; 15: 167-171.
4. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G: Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: Clinical significance and prognostic value of low molecular weight ('tubular') proteins. Am J Kidney Dis 1997; 29: 27-35.
5. Eddy AA: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 1989; 135: 719-733.
6. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, Egido J: Tubular NF--B and AP-1 activation in human proteinuric renal disease. Kidney Int 2001; 60: 1366-1377.
7. Nakatsuji S, Yamate J, Sakuma S: Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats. Vet Pathol 1998; 35: 352-360. (Pubitemid 129536642)
8. Sean Earley K, Cockwell P: Macrophages and progressive tubulointerstitial disease. Kidney Int 2005; 68: 437-455.
9. Magil AB: Intertitial foam cells and oxidized lipoprotein in human glomerular disease. Mod Pathol 1999; 12: 33-40.
10. Nolasco F, Cameron JS, Reuben R, Hartley B, Carvalho F, Coelho RA: Interstitial foam cells in the nephrotic syndrome belong to the monocyte/macrophage lineage. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1984; 21: 666-671.
11. Kurihara I, Saito T, Soma J, Sato H, Hotta O, Taguma Y, Ito S: Clinicopathological characteristics of interstitial foam cells in membranous nephropathy. Kidney Int Suppl 1999; 71:S144-S146.
12. Poucell S, Thoner P, Balfe JW, Baumal R: Interstitial foam cells in renal biopsies: An aid in differentiating idiopathic membranoproliferative glomerulonephritis (type I) and membranoproliferative glomerulonephritis associated with systemic lupus erythematosus. Child Nephrol Urol 1988-1989;9: 106-111.
13. Kurihara I, Hotta O, Taguma Y, Kurosawa K, Sudo K, Horigome I, Munakata T, Hirai M, Soma J, Sato H, Oguchi K, Saito T: A case of IgA nephropathy with numerous interstitial foam cells -analysis of infiltrating mononuclear leucocytes in renal tissue. Jpn J Nephrol 1994; 36: 774-778.
14. Franco M, Schmitt F, Rejaili WA, Viero RM, Bacchi CE: Renal interstitial foam cells are macrophages. Histopathology 1992; 20: 173-176.
15. Pasqui AL, Bova G, Maffei S, Auteri A: Immune factors in atherosclerosis. Ann Ital Med Int 2005; 20: 81-89.
16. Choudhury RP, Lee JM, Greaves DR: Mechanisms of disease: Macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis. Nat Clin Pract Cardiovasc Med 2005; 2: 309-315.
17. Kriszbacher I, Koppan M, Bodis J: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 353: 429-430.
18. Bobryshev YV: Monocyte recruitment and foam cell formation in atherosclerosis. Micron 2006; 37: 208-222.
19. Yoshimoto K, Wada T, Furuichi K, Sakai N, Iwata Y, Yokoyama H: CD68 and MCP-1/ CCR expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron Clin Pract 2004; 98:c25-c34. (Pubitemid 39279376)
20. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Nerem RM: The pathogenesis of atherosclerosis: An overview. Clin Cardiol 1991; 14(suppl 1):I1-I16.
21. Watanabe T, Hattori F, Tanaka K: An experimental study on the origin of foam cells in glomerulonephritis. Acta Pathol Jpn 1982; 32: 371-383.
22. White RH, Raafat F, Milford DV, Komianou F, Moghal NE: The Alport nephropathy: Clinicopathological correlations. Pediatr Nephrol 2005; 20: 897-903.
23. Berfield AK, Abrass CK: IGF-1 induces foam cell formation in rat glomerular mesangial cells. J Histochem Cytochem 2002; 50: 395-403.
24. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695.